Today, 3D modeling and printing technology can make a dramatic impact — even shortening some operations by 30-90 minutes. Looking ahead, that reduction will only grow as the technology is further integrated and becomes more advanced. The post The Pulse of Innovation: How 3D Models Can Prepare Surgeons for the Operating Room appeared first on MedCity News.

Gaps in reimbursement oversight and recovery will only widen, unless plans modernize how they detect, investigate, and recoup improper payments. The post Modernizing Payment Integrity in an Era of Systemic Fraud appeared first on MedCity News.

SCAN Health Plan and Costco are partnering to provide a suite of insurance products for seniors. The post SCAN, Costco Launch Medicare Partnership appeared first on MedCity News.

Ultragenyx Pharmaceutical’s Genglycos received accelerated FDA approval for glycogen storage disease type Ia, an inherited enzyme deficiency. It’s also the first approved gene therapy for Ultragenyx, which specializes in rare disease treatments. The post Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease appeared first on MedCity News.

Why the flood of consumer wellness devices demands clear boundaries between lifestyle improvement and clinical diagnostics The post The Imperative of Distinguishing Medical-Grade Devices from Wellness Tech appeared first on MedCity News.

As adoption accelerates, organizations must ensure that the use of AI strengthens and not weakens accountability and patient safety.   The post AI in Pharmacovigilance: Why Governance Will Define Success appeared first on MedCity News.

Happy Health’s $75 million round was from ARCH Venture Partners and OpenLoop. The post Happy Health Snags $75M to Support Home-Based Care appeared first on MedCity News.

Merck and Moderna said intismeran autogene, an mRNA cancer vaccine that prompts an immune response to proteins expressed by a patient’s tumors, met the main goal of a pivotal test in melanoma. It’s the most advanced trial in a 50/50 partnership evaluating the personalized cancer treatment in a wide range of tumor types. The post Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma appeared first on MedCity News.

The next healthcare revolution isn’t about treating osteoporosis, it’s about preserving mobility and healthspan. The post Why Bone Health Is Preventive Healthcare’s Next Big Category appeared first on MedCity News.

Included Health is partnering with Carrum Health to provide high-quality specialty care while reducing costs for employers. The post Included Health Taps Carrum Health for Value-Based Specialty Care appeared first on MedCity News.

Amylyx Pharmaceuticals’ avexitide led to statistically significant and clinically meaningful reductions in hypoglycemic events in patients with post-bariatric hypoglycemia (PBH). This peptide drug, a GLP-1 antagonist, was acquired from Eiger BioPharmaceuticals in 2024. The post Amylyx Plans FDA Filing After GLP-1 Drug Hits Trial Goals in Rare Metabolic Condition appeared first on MedCity News.

Rural hospitals need trained people, tested backups, downtime procedures, clinical continuity planning, and staff who know what to do when an alert fires. A framework won’t substitute for that work, but it helps organize it and makes progress measurable. The post Rural US Healthcare Has A Cybersecurity Problem — CMS Funding Can Help Fix the Part No One Sees appeared first on MedCity News.

KFF found that insurers denied 12%-18% of standard prior authorization requests in 2025, with significant variation among insurers and gaps in transparency. The post KFF: Insurers Denied 12%-18% of Prior Authorization Requests in 2025 appeared first on MedCity News.

Migraine drugs developer Slate Medicines is going public in a reverse merger with Fulcrum Therapeutics. The biotech’s lead antibody drug blocks two novel migraine targets, offering the potential for better efficacy compared to other next-generation migraine drugs in R&D. The post Slate Medicines’ Merger and $245M Private Placement Fuel Mission in Migraine appeared first on MedCity News.

Consumer diagnostics will be one of several discussions at the INVEST Digital Health conference focused on power shifting to the consumer in healthcare. The conference is scheduled for October 29 in Dallas at Pegasus Park, in partnership with Health Wildcatters. The post The Rise of Consumer Diagnostics and Emerging Trends appeared first on MedCity News.